Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine and orgasmic sexual experiences.

P L Morris1

  • 1Maryland Psychiatric Research Center, Baltimore.

International Journal of Psychiatry in Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Naltrexone for alcohol dependence: a randomized controlled trial.

Addiction (Abingdon, England)·2002
Same author

Cell- and stage-specific high-level expression of TBP-related factor 2 (TRF2) during mouse spermatogenesis.

Mechanisms of development·2001
Same author

Spermiogenesis deficiency in mice lacking the Trf2 gene.

Science (New York, N.Y.)·2001
Same author

Irradiation selectively inhibits expression from the androgen-dependent Pem homeobox gene promoter in sertoli cells.

Endocrinology·2001
Same author

Interleukin-6 regulation of kappa opioid receptor gene expression in primary sertoli cells.

Endocrine·2000
Same author

Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells.

Cancer research·2000

Fluoxetine, a common antidepressant, may cause unexpected sexual excitement as a side effect, particularly in patients with post-stroke depression. This dose-dependent reaction highlights a unique potential complication of serotonergic medications.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Post-stroke depression is a common complication affecting patient recovery.
  • Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, are frequently prescribed for depression.
  • Sexual dysfunction is a known potential side effect of SSRIs, but unique presentations require further investigation.

Observation:

  • A case report details a patient experiencing frequent, short episodes of sexual excitement, described as orgasmic, during fluoxetine treatment for post-stroke depression.
  • The patient's reported side effects were temporally associated with fluoxetine administration.
  • A clear dose-dependent relationship was observed between fluoxetine dosage and the frequency/intensity of sexual excitement episodes.

Findings:

Related Experiment Videos

  • Fluoxetine, a serotonergic medication, was associated with an unusual side effect of induced sexual stimulation.
  • The patient's neurological condition (post-stroke) may have predisposed them to this specific adverse effect.
  • The precise neurobiological mechanism underlying this SSRI-induced sexual excitement remains to be elucidated.

    • Implications:

    • This case suggests that serotonergic medications like fluoxetine might induce sexual stimulation, potentially presenting as orgasmic episodes.
    • Patients with central nervous system conditions, such as stroke, could be at an elevated risk for experiencing this unique side effect.
    • Further research is warranted to understand the mechanisms and prevalence of this potential complication in vulnerable patient populations.